2 stories mentioning SHE:300723Updated 24d ago
Every FINWIRES story that references SHE:300723, newest first.
China's drug regulator approved ApicHope Pharmaceutical (SHE:300723) subsidiary Guangzhou ApicHope's clinical trial for its APH03571 tablets, according to a Thursday filing with the Shanghai bourse.The trial will test the effects of the drug on adult patients with relapsed or refractory acute myeloid leukemia.
ApicHope Pharmaceutical (SHE:300723) unit Guangzhou Yipinhong Pharmaceutical obtained drug registration from China's medical products regulator for aminocaproic acid injection.The drug is used to treat various bleeding caused by hyperfibrinolysis, according to a Friday fling with the Shenzhen bourse.The approval is valid until May 2031.Shares of the pharmaceutical company were up 3% Friday.
